A neurotechnology company developing wearables to treat menstrual-related mental and physical symptoms has announced the successful closure of a $5 million seed funding round.
Samphire Neuroscience raises $5 million seed…
A neurotechnology company developing wearables to treat menstrual-related mental and physical symptoms has announced the successful closure of a $5 million seed funding round.